Employing Inhaled Saline For Young Kids With Cystic Fibrosis, Examined

Study evaluates if hypertonic saline is capable of reducing the rate of pulmonary exacerbations in children younger than 6 years of age with cystic fibrosis (CF), Margaret Rosenfeld, M.D., M.P.H., of Seattle Children’s Hospital, and colleagues, carried out the study. Inhaled hypertonic saline is recommended as therapy for patients 6 years or older with CF, but its efficacy has not been evaluated in patients younger than 6 years.

In the randomized trial, the active treatment group (n = 158) received 7 percent hypertonic saline and the control group (n = 163) received 0.9 percent isotonic saline, nebulized (dispensed in a fine mist) twice daily for 48 weeks. The researchers found that the average pulmonary exacerbation rate was similar between both groups. "Hypertonic saline did not reduce the rate of pulmonary exacerbations in these young children. In addition, hypertonic saline did not demonstrate any significant effects on secondary end points including weight, height, respiratory rate, oxygen saturation, antibiotic use, or parent report of respiratory signs and symptoms."

Cystic Fibrosis - Symptoms, Causes, Diagnosis, Treatment, Support Groups
Cystic fibrosis is a genetic disease involving the mucus and sweat glands and the medical world has still to find its cure

Source-Eurekalert

Cystic Fibrosis � New Drug to Target Basic Defect
A new drug VX-770 has been synthesized to treat cystic fibrosis patients. Going by reports, it is working wonders!

Key Found to Kill Cystic Fibrosis Superbug
Researchers from the Schulich School of Medicine & Dentistry at The University of Western Ontario , working with a group from Edinburgh, have discovered a way to kill the cystic fibrosis superbug

Inhaling Concentrated Saline Could Benefit Cystic Fibrosis Patients
Researchers at the University of North Carolina (UNC) at Chapel Hill have revealed that inhaling hypertonic saline is good for the lungs of patients affected by cystic fibrosis